A Study Collecting Surgical Tumor Samples for Generating Prostate Cancer Patient Derived Xenografts


About this study

The purpose of this  study is to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future testing of potential therapies and for understanding mechanisms of therapy resistance. 


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males, over 18 years of age
  • Hormone Refractory, Metastatic Prostate Cancer

Exclusion Criteria: 

  • Life expectancy of less than 3 months

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Liewei Wang, M.D., Ph.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer